stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) Debt to equity
Liquidia Corporation's debt to equity at the end of the quarter to 30 June 2026 was 0.9×, down 3.4× from fiscal 2025 (4.3×). Over the past ten years it has ranged from −0.7× (fiscal 2017) to 4.3× (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 4.3× | 199.63% |
| FY2024 | 1.4× | 46.61% |
| FY2023 | 1.0× | 339.06% |
| FY2022 | 0.2× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.2× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.1× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.5× | (30.64%) |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.9× | (44.90%) |
| Mar 2026 | 1.6× | (61.69%) |
| Dec 2025 | 4.3× | (51.01%) |
| Sep 2025 | 8.7× | (31.52%) |
| 32 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | −8.1× |
| PBH Prestige Consumer Healthcare Inc. compare | 0.0× |
| RGC Regencell Bioscience Holdings Limited compare | 0.0× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.0× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.1× |
| LNTH Lantheus Holdings, Inc. compare | 0.4× |
| LQDA Liquidia Corporation | 0.9× |
| HIMS Hims & Hers Health, Inc. compare | 4.2× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 6.0× |
| Drug Manufacturers Specialty & Generic industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement